Literature DB >> 7731690

The role of immunoglobulin kappa elements in c-myc activation.

K Hörtnagel1, J Mautner, L J Strobl, D A Wolf, B Christoph, C Geltinger, A Polack.   

Abstract

Burkitt's lymphoma cells are characterized by chromosomal translocations involving the proto-oncogene c-myc on chromosome 8 and one of the immunoglobulin gene loci on chromosome 2, 14 or 22. The translocated c-myc allele is transcriptionally activated, shows a preferential usage of promoter P1 over P2 (promoter shift) and lacks the ability to retain the transcription complex at the P2 promoter. In order to define the elements of the immunoglobulin kappa gene involved in deregulation of c-myc in a t(2;8) translocation, we designed constructs consisting of c-myc and different parts of the immunoglobulin kappa gene locus. Chromatin analysis of these stably transfected constructs revealed DNase I hypersensitive sites within the c-myc 5' region characteristic for an actively transcribed c-myc gene and three sites within the immunoglobulin kappa locus corresponding to the matrix attachment region, the intron and 3' enhancers, respectively. These three regulatory elements were necessary and sufficient for maximal c-myc activation and formation of the promoter shift. Kinetic nuclear run on experiments were performed to study the distribution of transcription complexes on c-myc exon 1 on constructs with and without the immunoglobulin kappa regulatory elements. The absence of a pausing polymerase complex at the c-myc P2 promoter could be demonstrated for constructs consisting of c-myc and the two kappa enhancers. Therefore the two enhancers are sufficient to relief the elongational block at the P2 promoter, however, the matrix attachment region is additionally required for maximal c-myc activation observed in Burkitt's lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731690

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.

Authors:  Martin S Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria G Masucci; Axel Polack; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.

Authors:  N E Wittekindt; K Hörtnagel; C Geltinger; A Polack
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

3.  Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses.

Authors:  S H Tan; D Bartsch; E Schwarz; H U Bernard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection.

Authors:  M Brielmeier; J M Béchet; M H Falk; M Pawlita; A Polack; G W Bornkamm
Journal:  Nucleic Acids Res       Date:  1998-05-01       Impact factor: 16.971

5.  Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II.

Authors:  T Albert; J Mautner; J O Funk; K Hörtnagel; A Pullner; D Eick
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.

Authors:  C Geltinger; K Hörtnagel; A Polack
Journal:  Gene Expr       Date:  1996

7.  c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

Authors:  A Polack; K Hörtnagel; A Pajic; B Christoph; B Baier; M Falk; J Mautner; C Geltinger; G W Bornkamm; B Kempkes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 8.  Epstein-Barr virus and Burkitt lymphoma.

Authors:  G Brady; G J MacArthur; P J Farrell
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

9.  SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements.

Authors:  O Nayler; W Strätling; J P Bourquin; I Stagljar; L Lindemann; H Jasper; A M Hartmann; F O Fackelmayer; A Ullrich; S Stamm
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

Review 10.  From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics.

Authors:  J Bode; S Goetze; H Heng; S A Krawetz; C Benham
Journal:  Chromosome Res       Date:  2003       Impact factor: 4.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.